The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rivaroxaban API Market Research Report 2024
Synopsis
Rivaroxaban belongs to the class of antithrombotic agents. Rivaroxaban reduces a risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischemic attack. It is indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.
The global Rivaroxaban API market was valued at US$ 7995 million in 2023 and is anticipated to reach US$ 13780 million by 2030, witnessing a CAGR of 8.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rivaroxaban API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rivaroxaban API.
Report Scope
The Rivaroxaban API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rivaroxaban API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rivaroxaban API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy's Laboratories
Actis Generics Pvt Ltd.
ZCL Chemicals Limited
Medichem S.A
UQUIFA
Inke
Teva Pharmaceutical Industries Ltd.
Zhejiang Huahai Pharmaceutial. Co., Ltd.
Morepen Labs
Shaanxi Hanjiang Pharmaceutical
Jiangsu Jiayi
Shanghai Haoyuan
Nanjing Hicin
Segment by Type
Purity≥98%
Purity<98%
Segment by Application
Rivaroxaban Tablets
Others
Production by Region
North America
Europe
China
India
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rivaroxaban API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Rivaroxaban API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Rivaroxaban API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Rivaroxaban belongs to the class of antithrombotic agents. Rivaroxaban reduces a risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischemic attack. It is indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.
The global Rivaroxaban API market was valued at US$ 7995 million in 2023 and is anticipated to reach US$ 13780 million by 2030, witnessing a CAGR of 8.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rivaroxaban API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rivaroxaban API.
Report Scope
The Rivaroxaban API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rivaroxaban API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rivaroxaban API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy's Laboratories
Actis Generics Pvt Ltd.
ZCL Chemicals Limited
Medichem S.A
UQUIFA
Inke
Teva Pharmaceutical Industries Ltd.
Zhejiang Huahai Pharmaceutial. Co., Ltd.
Morepen Labs
Shaanxi Hanjiang Pharmaceutical
Jiangsu Jiayi
Shanghai Haoyuan
Nanjing Hicin
Segment by Type
Purity≥98%
Purity<98%
Segment by Application
Rivaroxaban Tablets
Others
Production by Region
North America
Europe
China
India
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rivaroxaban API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Rivaroxaban API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Rivaroxaban API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Rivaroxaban API Market Overview
1.1 Product Definition
1.2 Rivaroxaban API Segment by Type
1.2.1 Global Rivaroxaban API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity<98%
1.3 Rivaroxaban API Segment by Application
1.3.1 Global Rivaroxaban API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Rivaroxaban Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Rivaroxaban API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Rivaroxaban API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Rivaroxaban API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Rivaroxaban API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Rivaroxaban API Production Market Share by Manufacturers (2019-2024)
2.2 Global Rivaroxaban API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Rivaroxaban API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Rivaroxaban API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Rivaroxaban API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Rivaroxaban API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Rivaroxaban API, Product Offered and Application
2.8 Global Key Manufacturers of Rivaroxaban API, Date of Enter into This Industry
2.9 Rivaroxaban API Market Competitive Situation and Trends
2.9.1 Rivaroxaban API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Rivaroxaban API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Rivaroxaban API Production by Region
3.1 Global Rivaroxaban API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Rivaroxaban API Production Value by Region (2019-2030)
3.2.1 Global Rivaroxaban API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Rivaroxaban API by Region (2025-2030)
3.3 Global Rivaroxaban API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Rivaroxaban API Production by Region (2019-2030)
3.4.1 Global Rivaroxaban API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Rivaroxaban API by Region (2025-2030)
3.5 Global Rivaroxaban API Market Price Analysis by Region (2019-2024)
3.6 Global Rivaroxaban API Production and Value, Year-over-Year Growth
3.6.1 North America Rivaroxaban API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Rivaroxaban API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Rivaroxaban API Production Value Estimates and Forecasts (2019-2030)
3.6.4 India Rivaroxaban API Production Value Estimates and Forecasts (2019-2030)
4 Rivaroxaban API Consumption by Region
4.1 Global Rivaroxaban API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Rivaroxaban API Consumption by Region (2019-2030)
4.2.1 Global Rivaroxaban API Consumption by Region (2019-2024)
4.2.2 Global Rivaroxaban API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Rivaroxaban API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Rivaroxaban API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Rivaroxaban API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Rivaroxaban API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Rivaroxaban API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Rivaroxaban API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Rivaroxaban API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Rivaroxaban API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Rivaroxaban API Production by Type (2019-2030)
5.1.1 Global Rivaroxaban API Production by Type (2019-2024)
5.1.2 Global Rivaroxaban API Production by Type (2025-2030)
5.1.3 Global Rivaroxaban API Production Market Share by Type (2019-2030)
5.2 Global Rivaroxaban API Production Value by Type (2019-2030)
5.2.1 Global Rivaroxaban API Production Value by Type (2019-2024)
5.2.2 Global Rivaroxaban API Production Value by Type (2025-2030)
5.2.3 Global Rivaroxaban API Production Value Market Share by Type (2019-2030)
5.3 Global Rivaroxaban API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Rivaroxaban API Production by Application (2019-2030)
6.1.1 Global Rivaroxaban API Production by Application (2019-2024)
6.1.2 Global Rivaroxaban API Production by Application (2025-2030)
6.1.3 Global Rivaroxaban API Production Market Share by Application (2019-2030)
6.2 Global Rivaroxaban API Production Value by Application (2019-2030)
6.2.1 Global Rivaroxaban API Production Value by Application (2019-2024)
6.2.2 Global Rivaroxaban API Production Value by Application (2025-2030)
6.2.3 Global Rivaroxaban API Production Value Market Share by Application (2019-2030)
6.3 Global Rivaroxaban API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Dr. Reddy's Laboratories
7.1.1 Dr. Reddy's Laboratories Rivaroxaban API Corporation Information
7.1.2 Dr. Reddy's Laboratories Rivaroxaban API Product Portfolio
7.1.3 Dr. Reddy's Laboratories Rivaroxaban API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.1.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.2 Actis Generics Pvt Ltd.
7.2.1 Actis Generics Pvt Ltd. Rivaroxaban API Corporation Information
7.2.2 Actis Generics Pvt Ltd. Rivaroxaban API Product Portfolio
7.2.3 Actis Generics Pvt Ltd. Rivaroxaban API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Actis Generics Pvt Ltd. Main Business and Markets Served
7.2.5 Actis Generics Pvt Ltd. Recent Developments/Updates
7.3 ZCL Chemicals Limited
7.3.1 ZCL Chemicals Limited Rivaroxaban API Corporation Information
7.3.2 ZCL Chemicals Limited Rivaroxaban API Product Portfolio
7.3.3 ZCL Chemicals Limited Rivaroxaban API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 ZCL Chemicals Limited Main Business and Markets Served
7.3.5 ZCL Chemicals Limited Recent Developments/Updates
7.4 Medichem S.A
7.4.1 Medichem S.A Rivaroxaban API Corporation Information
7.4.2 Medichem S.A Rivaroxaban API Product Portfolio
7.4.3 Medichem S.A Rivaroxaban API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Medichem S.A Main Business and Markets Served
7.4.5 Medichem S.A Recent Developments/Updates
7.5 UQUIFA
7.5.1 UQUIFA Rivaroxaban API Corporation Information
7.5.2 UQUIFA Rivaroxaban API Product Portfolio
7.5.3 UQUIFA Rivaroxaban API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 UQUIFA Main Business and Markets Served
7.5.5 UQUIFA Recent Developments/Updates
7.6 Inke
7.6.1 Inke Rivaroxaban API Corporation Information
7.6.2 Inke Rivaroxaban API Product Portfolio
7.6.3 Inke Rivaroxaban API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Inke Main Business and Markets Served
7.6.5 Inke Recent Developments/Updates
7.7 Teva Pharmaceutical Industries Ltd.
7.7.1 Teva Pharmaceutical Industries Ltd. Rivaroxaban API Corporation Information
7.7.2 Teva Pharmaceutical Industries Ltd. Rivaroxaban API Product Portfolio
7.7.3 Teva Pharmaceutical Industries Ltd. Rivaroxaban API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Teva Pharmaceutical Industries Ltd. Main Business and Markets Served
7.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
7.8 Zhejiang Huahai Pharmaceutial. Co., Ltd.
7.8.1 Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Corporation Information
7.8.2 Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Product Portfolio
7.8.3 Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Zhejiang Huahai Pharmaceutial. Co., Ltd. Main Business and Markets Served
7.7.5 Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Developments/Updates
7.9 Morepen Labs
7.9.1 Morepen Labs Rivaroxaban API Corporation Information
7.9.2 Morepen Labs Rivaroxaban API Product Portfolio
7.9.3 Morepen Labs Rivaroxaban API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Morepen Labs Main Business and Markets Served
7.9.5 Morepen Labs Recent Developments/Updates
7.10 Shaanxi Hanjiang Pharmaceutical
7.10.1 Shaanxi Hanjiang Pharmaceutical Rivaroxaban API Corporation Information
7.10.2 Shaanxi Hanjiang Pharmaceutical Rivaroxaban API Product Portfolio
7.10.3 Shaanxi Hanjiang Pharmaceutical Rivaroxaban API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Shaanxi Hanjiang Pharmaceutical Main Business and Markets Served
7.10.5 Shaanxi Hanjiang Pharmaceutical Recent Developments/Updates
7.11 Jiangsu Jiayi
7.11.1 Jiangsu Jiayi Rivaroxaban API Corporation Information
7.11.2 Jiangsu Jiayi Rivaroxaban API Product Portfolio
7.11.3 Jiangsu Jiayi Rivaroxaban API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Jiangsu Jiayi Main Business and Markets Served
7.11.5 Jiangsu Jiayi Recent Developments/Updates
7.12 Shanghai Haoyuan
7.12.1 Shanghai Haoyuan Rivaroxaban API Corporation Information
7.12.2 Shanghai Haoyuan Rivaroxaban API Product Portfolio
7.12.3 Shanghai Haoyuan Rivaroxaban API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Shanghai Haoyuan Main Business and Markets Served
7.12.5 Shanghai Haoyuan Recent Developments/Updates
7.13 Nanjing Hicin
7.13.1 Nanjing Hicin Rivaroxaban API Corporation Information
7.13.2 Nanjing Hicin Rivaroxaban API Product Portfolio
7.13.3 Nanjing Hicin Rivaroxaban API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Nanjing Hicin Main Business and Markets Served
7.13.5 Nanjing Hicin Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Rivaroxaban API Industry Chain Analysis
8.2 Rivaroxaban API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Rivaroxaban API Production Mode & Process
8.4 Rivaroxaban API Sales and Marketing
8.4.1 Rivaroxaban API Sales Channels
8.4.2 Rivaroxaban API Distributors
8.5 Rivaroxaban API Customers
9 Rivaroxaban API Market Dynamics
9.1 Rivaroxaban API Industry Trends
9.2 Rivaroxaban API Market Drivers
9.3 Rivaroxaban API Market Challenges
9.4 Rivaroxaban API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Rivaroxaban API Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Rivaroxaban API Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Rivaroxaban API Production Capacity (Kg) by Manufacturers in 2023
Table 4. Global Rivaroxaban API Production by Manufacturers (2019-2024) & (Kg)
Table 5. Global Rivaroxaban API Production Market Share by Manufacturers (2019-2024)
Table 6. Global Rivaroxaban API Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Rivaroxaban API Production Value Share by Manufacturers (2019-2024)
Table 8. Global Rivaroxaban API Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rivaroxaban API as of 2023)
Table 10. Global Market Rivaroxaban API Average Price by Manufacturers (US$/Kg) & (2019-2024)
Table 11. Manufacturers Rivaroxaban API Production Sites and Area Served
Table 12. Manufacturers Rivaroxaban API Product Types
Table 13. Global Rivaroxaban API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Rivaroxaban API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Rivaroxaban API Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Rivaroxaban API Production Value Market Share by Region (2019-2024)
Table 18. Global Rivaroxaban API Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Rivaroxaban API Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Rivaroxaban API Production Comparison by Region: 2019 VS 2023 VS 2030 (Kg)
Table 21. Global Rivaroxaban API Production (Kg) by Region (2019-2024)
Table 22. Global Rivaroxaban API Production Market Share by Region (2019-2024)
Table 23. Global Rivaroxaban API Production (Kg) Forecast by Region (2025-2030)
Table 24. Global Rivaroxaban API Production Market Share Forecast by Region (2025-2030)
Table 25. Global Rivaroxaban API Market Average Price (US$/Kg) by Region (2019-2024)
Table 26. Global Rivaroxaban API Market Average Price (US$/Kg) by Region (2025-2030)
Table 27. Global Rivaroxaban API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kg)
Table 28. Global Rivaroxaban API Consumption by Region (2019-2024) & (Kg)
Table 29. Global Rivaroxaban API Consumption Market Share by Region (2019-2024)
Table 30. Global Rivaroxaban API Forecasted Consumption by Region (2025-2030) & (Kg)
Table 31. Global Rivaroxaban API Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Rivaroxaban API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 33. North America Rivaroxaban API Consumption by Country (2019-2024) & (Kg)
Table 34. North America Rivaroxaban API Consumption by Country (2025-2030) & (Kg)
Table 35. Europe Rivaroxaban API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 36. Europe Rivaroxaban API Consumption by Country (2019-2024) & (Kg)
Table 37. Europe Rivaroxaban API Consumption by Country (2025-2030) & (Kg)
Table 38. Asia Pacific Rivaroxaban API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kg)
Table 39. Asia Pacific Rivaroxaban API Consumption by Region (2019-2024) & (Kg)
Table 40. Asia Pacific Rivaroxaban API Consumption by Region (2025-2030) & (Kg)
Table 41. Latin America, Middle East & Africa Rivaroxaban API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kg)
Table 42. Latin America, Middle East & Africa Rivaroxaban API Consumption by Country (2019-2024) & (Kg)
Table 43. Latin America, Middle East & Africa Rivaroxaban API Consumption by Country (2025-2030) & (Kg)
Table 44. Global Rivaroxaban API Production (Kg) by Type (2019-2024)
Table 45. Global Rivaroxaban API Production (Kg) by Type (2025-2030)
Table 46. Global Rivaroxaban API Production Market Share by Type (2019-2024)
Table 47. Global Rivaroxaban API Production Market Share by Type (2025-2030)
Table 48. Global Rivaroxaban API Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Rivaroxaban API Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Rivaroxaban API Production Value Share by Type (2019-2024)
Table 51. Global Rivaroxaban API Production Value Share by Type (2025-2030)
Table 52. Global Rivaroxaban API Price (US$/Kg) by Type (2019-2024)
Table 53. Global Rivaroxaban API Price (US$/Kg) by Type (2025-2030)
Table 54. Global Rivaroxaban API Production (Kg) by Application (2019-2024)
Table 55. Global Rivaroxaban API Production (Kg) by Application (2025-2030)
Table 56. Global Rivaroxaban API Production Market Share by Application (2019-2024)
Table 57. Global Rivaroxaban API Production Market Share by Application (2025-2030)
Table 58. Global Rivaroxaban API Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Rivaroxaban API Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Rivaroxaban API Production Value Share by Application (2019-2024)
Table 61. Global Rivaroxaban API Production Value Share by Application (2025-2030)
Table 62. Global Rivaroxaban API Price (US$/Kg) by Application (2019-2024)
Table 63. Global Rivaroxaban API Price (US$/Kg) by Application (2025-2030)
Table 64. Dr. Reddy's Laboratories Rivaroxaban API Corporation Information
Table 65. Dr. Reddy's Laboratories Specification and Application
Table 66. Dr. Reddy's Laboratories Rivaroxaban API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 67. Dr. Reddy's Laboratories Main Business and Markets Served
Table 68. Dr. Reddy's Laboratories Recent Developments/Updates
Table 69. Actis Generics Pvt Ltd. Rivaroxaban API Corporation Information
Table 70. Actis Generics Pvt Ltd. Specification and Application
Table 71. Actis Generics Pvt Ltd. Rivaroxaban API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 72. Actis Generics Pvt Ltd. Main Business and Markets Served
Table 73. Actis Generics Pvt Ltd. Recent Developments/Updates
Table 74. ZCL Chemicals Limited Rivaroxaban API Corporation Information
Table 75. ZCL Chemicals Limited Specification and Application
Table 76. ZCL Chemicals Limited Rivaroxaban API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 77. ZCL Chemicals Limited Main Business and Markets Served
Table 78. ZCL Chemicals Limited Recent Developments/Updates
Table 79. Medichem S.A Rivaroxaban API Corporation Information
Table 80. Medichem S.A Specification and Application
Table 81. Medichem S.A Rivaroxaban API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 82. Medichem S.A Main Business and Markets Served
Table 83. Medichem S.A Recent Developments/Updates
Table 84. UQUIFA Rivaroxaban API Corporation Information
Table 85. UQUIFA Specification and Application
Table 86. UQUIFA Rivaroxaban API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 87. UQUIFA Main Business and Markets Served
Table 88. UQUIFA Recent Developments/Updates
Table 89. Inke Rivaroxaban API Corporation Information
Table 90. Inke Specification and Application
Table 91. Inke Rivaroxaban API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 92. Inke Main Business and Markets Served
Table 93. Inke Recent Developments/Updates
Table 94. Teva Pharmaceutical Industries Ltd. Rivaroxaban API Corporation Information
Table 95. Teva Pharmaceutical Industries Ltd. Specification and Application
Table 96. Teva Pharmaceutical Industries Ltd. Rivaroxaban API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 97. Teva Pharmaceutical Industries Ltd. Main Business and Markets Served
Table 98. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 99. Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Corporation Information
Table 100. Zhejiang Huahai Pharmaceutial. Co., Ltd. Specification and Application
Table 101. Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 102. Zhejiang Huahai Pharmaceutial. Co., Ltd. Main Business and Markets Served
Table 103. Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Developments/Updates
Table 104. Morepen Labs Rivaroxaban API Corporation Information
Table 105. Morepen Labs Specification and Application
Table 106. Morepen Labs Rivaroxaban API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 107. Morepen Labs Main Business and Markets Served
Table 108. Morepen Labs Recent Developments/Updates
Table 109. Shaanxi Hanjiang Pharmaceutical Rivaroxaban API Corporation Information
Table 110. Shaanxi Hanjiang Pharmaceutical Specification and Application
Table 111. Shaanxi Hanjiang Pharmaceutical Rivaroxaban API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 112. Shaanxi Hanjiang Pharmaceutical Main Business and Markets Served
Table 113. Shaanxi Hanjiang Pharmaceutical Recent Developments/Updates
Table 114. Jiangsu Jiayi Rivaroxaban API Corporation Information
Table 115. Jiangsu Jiayi Specification and Application
Table 116. Jiangsu Jiayi Rivaroxaban API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 117. Jiangsu Jiayi Main Business and Markets Served
Table 118. Jiangsu Jiayi Recent Developments/Updates
Table 119. Shanghai Haoyuan Rivaroxaban API Corporation Information
Table 120. Shanghai Haoyuan Specification and Application
Table 121. Shanghai Haoyuan Rivaroxaban API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 122. Shanghai Haoyuan Main Business and Markets Served
Table 123. Shanghai Haoyuan Recent Developments/Updates
Table 124. Nanjing Hicin Rivaroxaban API Corporation Information
Table 125. Nanjing Hicin Specification and Application
Table 126. Nanjing Hicin Rivaroxaban API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 127. Nanjing Hicin Main Business and Markets Served
Table 128. Nanjing Hicin Recent Developments/Updates
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Rivaroxaban API Distributors List
Table 132. Rivaroxaban API Customers List
Table 133. Rivaroxaban API Market Trends
Table 134. Rivaroxaban API Market Drivers
Table 135. Rivaroxaban API Market Challenges
Table 136. Rivaroxaban API Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rivaroxaban API
Figure 2. Global Rivaroxaban API Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Rivaroxaban API Market Share by Type: 2023 VS 2030
Figure 4. Purity≥98% Product Picture
Figure 5. Purity<98% Product Picture
Figure 6. Global Rivaroxaban API Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Rivaroxaban API Market Share by Application: 2023 VS 2030
Figure 8. Rivaroxaban Tablets
Figure 9. Others
Figure 10. Global Rivaroxaban API Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Rivaroxaban API Production Value (US$ Million) & (2019-2030)
Figure 12. Global Rivaroxaban API Production Capacity (Kg) & (2019-2030)
Figure 13. Global Rivaroxaban API Production (Kg) & (2019-2030)
Figure 14. Global Rivaroxaban API Average Price (US$/Kg) & (2019-2030)
Figure 15. Rivaroxaban API Report Years Considered
Figure 16. Rivaroxaban API Production Share by Manufacturers in 2023
Figure 17. Rivaroxaban API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. The Global 5 and 10 Largest Players: Market Share by Rivaroxaban API Revenue in 2023
Figure 19. Global Rivaroxaban API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Rivaroxaban API Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 21. Global Rivaroxaban API Production Comparison by Region: 2019 VS 2023 VS 2030 (Kg)
Figure 22. Global Rivaroxaban API Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. North America Rivaroxaban API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 24. Europe Rivaroxaban API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. China Rivaroxaban API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. India Rivaroxaban API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Global Rivaroxaban API Consumption by Region: 2019 VS 2023 VS 2030 (Kg)
Figure 28. Global Rivaroxaban API Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 30. North America Rivaroxaban API Consumption Market Share by Country (2019-2030)
Figure 31. Canada Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 32. U.S. Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 33. Europe Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 34. Europe Rivaroxaban API Consumption Market Share by Country (2019-2030)
Figure 35. Germany Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 36. France Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 37. U.K. Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 38. Italy Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 39. Russia Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 40. Asia Pacific Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 41. Asia Pacific Rivaroxaban API Consumption Market Share by Regions (2019-2030)
Figure 42. China Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 43. Japan Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 44. South Korea Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 45. China Taiwan Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 46. Southeast Asia Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 47. India Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 48. Latin America, Middle East & Africa Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 49. Latin America, Middle East & Africa Rivaroxaban API Consumption Market Share by Country (2019-2030)
Figure 50. Mexico Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 51. Brazil Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 52. Turkey Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 53. GCC Countries Rivaroxaban API Consumption and Growth Rate (2019-2024) & (Kg)
Figure 54. Global Production Market Share of Rivaroxaban API by Type (2019-2030)
Figure 55. Global Production Value Market Share of Rivaroxaban API by Type (2019-2030)
Figure 56. Global Rivaroxaban API Price (US$/Kg) by Type (2019-2030)
Figure 57. Global Production Market Share of Rivaroxaban API by Application (2019-2030)
Figure 58. Global Production Value Market Share of Rivaroxaban API by Application (2019-2030)
Figure 59. Global Rivaroxaban API Price (US$/Kg) by Application (2019-2030)
Figure 60. Rivaroxaban API Value Chain
Figure 61. Rivaroxaban API Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
